The V-HeFT Trial is a trial establishing that therapy with isosorbide dinitrate and hydralazine reduced mortality in patients systolic heart failure. It was named V-Heft because of these very hefty results.
The V-HeFT Trial is a trial establishing that therapy with isosorbide dinitrate and hydralazine reduced mortality in patients systolic heart failure. It was named V-Heft because of these very hefty results.
